---
agency: Department of Health and Human Services
applicant_types:
- Federally Recognized lndian Tribal Governments
- Native American Organizations (includes lndian groups, cooperatives, corporations,
  partnerships, associations)
- Other private institutions/organizations
- Other public institution/organization
- Private nonprofit institution/organization (includes institutions of higher education
  and hospitals)
- Profit organization
- Public nonprofit institution/organization (includes institutions of higher education
  and hospitals)
- Quasi-public nonprofit institution/organization
- State (includes District of Columbia, public institutions of higher education and
  hospitals)
- U.S. Territories and possessions (includes institutions of higher education and
  hospitals)
assistance_types:
- Project Grants
beneficiary_types:
- Anyone/general public
- Federal
- Federally Recognized Indian Tribal Governments
- Individual/Family
- Local
- Minority group
- Native American Organizations
- Other private institution/organization
- Other public institution/organization
- Private nonprofit institution/organization
- Profit organization
- Public nonprofit institution/organization
- Quasi-public nonprofit organization
- State
- U.S. Territories
categories:
- Disaster Prevention and Relief - Emergency Health Services
cfda: '93.360'
fiscal_year: '2022'
layout: program
objective: "The purpose of this program is to coordinate the acceleration of countermeasure\
  \ and product advanced research and development by\u2014(A) facilitating collaboration\
  \ between the Department of Health and Human Services and other Federal agencies,\
  \ relevant industries, academia, and other persons, with respect to such advanced\
  \ research and development; (B) promoting countermeasure and product advanced research\
  \ and development; (C) facilitating contacts between interested persons and the\
  \ offices or employees authorized by the Secretary to advise such persons regarding\
  \ requirements under the Federal Food, Drug, and Cosmetic Act and under section\
  \ 351 of the Public Health Service Act; and (D) promoting innovation to reduce the\
  \ time and cost of countermeasure and product advanced research and development.\
  \  The Public Health Service Act at 42 U.S.C. 247d-6a defines a qualified countermeasure\
  \ as \u201C\u2026a drug (as that term is defined by section 321(g)(1) of title 21),\
  \ biological product (as that term is defined by section 262(i) of this title),\
  \ or device (as that term is defined by section 321(h) of title 21), that the Secretary\
  \ determines to be a priority (consistent with sections 182(2) and 184(a) of title\
  \ 6) to - (i) diagnose, mitigate, prevent, or treat harm from any biological agent\
  \ (including organisms that cause an infectious disease) or toxin, chemical, radiological,\
  \ or nuclear agent that may cause a public health emergency affecting national security;\
  \ or (ii) diagnose, mitigate, prevent, or treat harm from a condition that may result\
  \ in adverse health consequences or death and may be caused by administering a drug,\
  \ biological product, or device that is used as described in this subparagraph\u201D"
obligations: '[{"x":"2022","sam_estimate":0.0,"sam_actual":0.0,"usa_spending_actual":206612976.16},{"x":"2023","sam_estimate":0.0,"sam_actual":0.0,"usa_spending_actual":1391186382.85},{"x":"2024","sam_estimate":0.0,"sam_actual":0.0,"usa_spending_actual":0.0}]'
permalink: /program/93.360.html
popular_name: ''
sam_url: https://sam.gov/fal/cdc8fb6193484ec2acda7590735dd3c1/view
sub-agency: Immed Office of the Secretary of Health and Human Services
title: Biomedical Advanced Research and Development Authority (BARDA), Biodefense
  Medical Countermeasure Development
---
